ROLE OF CYCLIN D1 IN THE MECHANISMS OF TAMOXIFEN RESISTANCE
Hormone-receptor positive breast cancer is the most common molecular subtype and represents 60–75 % of all breast cancers (BC). The presence of specific molecular targets such as the estrogen/progesterone receptor determines the use of hormone therapy for patients with this subtype. Tamoxifen, a sel...
| Main Authors: | , , , , , , |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
Tomsk National Research Medical Center of the Russian Academy of Sciences
2020-09-01
|
| Series: | Sibirskij Onkologičeskij Žurnal |
| Subjects: | |
| Online Access: | https://www.siboncoj.ru/jour/article/view/1540 |